9.58
Lenz Therapeutics Inc Borsa (LENZ) Ultime notizie
Squarepoint Ops LLC Acquires Significant Stake in LENZ Therapeutics Inc - GuruFocus
LENZ Therapeutics (LENZ) price target decreased by 20.47% to 39.10 - MSN
Aug Highlights: Can LENZ Therapeutics Inc sustain its profitability2026 Action & Growth Oriented Trade Recommendations - baoquankhu1.vn
Rate Cut: Will LENZ Therapeutics Inc outperform its industry peers2026 Setups & Reliable Intraday Trade Alerts - baoquankhu1.vn
LENZ Stock Price, Quote & Chart | LENZ THERAPEUTICS INC (NASDAQ:LENZ) - ChartMill
Is LENZ Therapeutics Inc stock a smart retirement pickTrade Exit Summary & Entry Point Confirmation Signals - baoquankhu1.vn
Squarepoint entities hold multiple 5% stakes in LENZ (NASDAQ: LENZ) - Stock Titan
Sentiment Recap: What is the cash position of LENZ Therapeutics IncMarket Growth Review & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Insider Spends US$251k Buying More Shares In LENZ Therapeutics - Moomoo
LENZ Therapeutics: Speculative But Strong Buy (NASDAQ:LENZ) - Seeking Alpha
President of LENZ Therapeutics Evert Schimmelpennink Buys 57% More Shares - simplywall.st
President of LENZ Therapeutics Picks Up 57% More Stock - Yahoo Finance
Tech Rally: What is the cash position of LENZ Therapeutics Inc2026 Technical Patterns & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Institution Moves: Is LENZ Therapeutics Inc a strong candidate for buy and holdProduct Launch & Technical Pattern Alert System - baoquankhu1.vn
Insider Buying: Jeffrey George Acquires Shares of LENZ Therapeutics Inc (LENZ) - GuruFocus
Lenz Therapeutics CFO Chevallard buys $64k in stock By Investing.com - Investing.com Australia
Lenz Therapeutics director George buys $49,890 in stock By Investing.com - Investing.com Canada
Lenz Therapeutics CEO Schimmelpennink buys $251k in stock By Investing.com - Investing.com Canada
Lenz Therapeutics Insider Bought Shares Worth $251,411, According to a Recent SEC Filing - marketscreener.com
Lenz Therapeutics director George buys $49,890 in stock - Investing.com
Lenz Therapeutics CFO Chevallard buys $64k in stock - Investing.com
Director at LENZ Therapeutics (LENZ) buys 5,592 shares in open-market trade - Stock Titan
LENZ Therapeutics (LENZ) CEO adds 28,089 shares in open-market stock purchase - Stock Titan
LENZ Therapeutics (LENZ) CFO buys 7,500 shares of stock - Stock Titan
LENZ Therapeutics Hits 52-Week Low at USD 10.44 Amid Ongoing Struggles - marketsmojo.com
Analysts Just Slashed Their LENZ Therapeutics, Inc. (NASDAQ:LENZ) EPS Numbers - simplywall.st
The Consensus EPS Estimates For LENZ Therapeutics, Inc. (NASDAQ:LENZ) Just Fell Dramatically - Yahoo Finance
Lenz Therapeutics Earnings Call: High Spend, Growing Traction - TipRanks
LENZ Therapeutics Hits 52-Week Low at USD 11.22 Amidst Declining Performance - Markets Mojo
LENZ Therapeutics Hits 52-Week Low at $8.86 Amid Ongoing Struggles - Markets Mojo
LENZ Therapeutics: Q4 Results Highlight A Worrying Lack Of Market Demand (Rating Downgrade) - Seeking Alpha
Why Lenz Therapeutics Stock Plummeted by Almost 20% This Week - Yahoo Finance
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
HC Wainwright Issues Positive Forecast for LENZ Earnings - MarketBeat
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Analysts Are Cutting Their Estimates: Here's What You Need To Know - simplywall.st
LENZ Therapeutics (NASDAQ:LENZ) Price Target Lowered to $26.00 at Citigroup - Defense World
Citigroup Has Lowered Expectations for LENZ Therapeutics (NASDAQ:LENZ) Stock Price - MarketBeat
FY2028 EPS Forecast for LENZ Therapeutics Lowered by Analyst - MarketBeat
Valuation Update: What is the cash position of LENZ Therapeutics Inc2026 Market Outlook & Daily Profit Focused Stock Screening - baoquankhu1.vn
LENZ Therapeutics stock rating reiterated at Buy by H.C. Wainwright - Investing.com UK
Bank of America Has Lowered Expectations for LENZ Therapeutics (NASDAQ:LENZ) Stock Price - MarketBeat
LENZ Therapeutics stock rating reiterated at Buy by H.C. Wainwright By Investing.com - Investing.com Australia
LENZ Therapeutics, Inc. Q4 2025 Earnings Call Summary - finance.yahoo.com
LENZ Therapeutics Reports Fourth Quarter, Full-Year Financial Results as Sales of Presbyopia Drop Gain Momentum - VisionMonday.com
VIZZ by LENZ Therapeutics: FDA-Approved Once-Daily Eye Drop for Presbyopia Treatment and Market Opportunity 32 - Minichart
Why Lenz Therapeutics Stock Crashed Today - AOL.com
LENZ Therapeutics (NASDAQ:LENZ) Posts Earnings Results, Misses Expectations By $0.25 EPS - MarketBeat
LENZ Therapeutics 2025 10-K: $19.1M Revenue, $(2.85) EPS - TradingView
LENZ Therapeutics Inc (LENZ) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... By GuruFocus - Investing.com Canada
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):